A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
Oral supplementation does not have our preference
They help people who have trouble absorbing vitamin B12 from their diet or supplements, such as those with anemia, older adults, and people with gastrointestinal health issues
A more comprehensive understanding of the relationship between lactylation and other PTMs, as well as the regulatory strategies for protein lactylation, will aid in developing new therapeutic ideas and expanding the treatment potential of lactylation modifications in CNS diseases
pylori ) is a bacterium that induces chronic gastric inflammation and is the most important cause of peptic ulcer worldwide